Product Images Steglujan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Steglujan NDC 0006-5368 by Merck Sharp & Dohme Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - steglujan 01

Chemical Structure - steglujan 01

Chemical Structure - steglujan 02

Chemical Structure - steglujan 02

Figure 1 - steglujan 03

Figure 1 - steglujan 03

Figure 2 - steglujan 04

Figure 2 - steglujan 04

Figure 3 - steglujan 05

Figure 3 - steglujan 05

PRINCIPAL DISPLAY PANEL - 5 mg/100 mg Tablet Bottle Label - steglujan 06

PRINCIPAL DISPLAY PANEL - 5 mg/100 mg Tablet Bottle Label - steglujan 06

This is a description of a medication with NDC code 0006-5367-03. It is a pack of 30 tablets of Steglujan, a drug containing 5mg/100mg of sitagliptin and ertugliflozin. It also includes a medication guide. There is space reserved for a 2D serialization barcode that contains information about the product's serial number, expiry, and lot number.*

PRINCIPAL DISPLAY PANEL - 15 mg/100 mg Tablet Bottle Label - steglujan 07

PRINCIPAL DISPLAY PANEL - 15 mg/100 mg Tablet Bottle Label - steglujan 07

Steglujan is a medication that comes in tablet form and contains ertugliflozin and sitagliptin. The GTIN code for this medication is 0030065368030. Each tablet consists of 19.43mg of ertugliflozin and 128.5mg of sitagliptin phosphate. It is recommended to give a Medication Guide along with the tablets. The usual dosage is not available. Store Steglujan at 20°C25° and protect from moisture.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.